Ligand validation:6REZ

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 6REZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6REZ_OLC_E_303	12%	31%	0.239	0.878	1.5	1.27	1	2	0	0	40%	0.4
6REZ_OLC_C_302	8%	32%	0.292	0.865	1.43	1.28	1	2	4	0	44%	0.44
6REZ_OLC_A_303	8%	27%	0.304	0.882	1.48	1.46	1	2	4	0	40%	0.4
6REZ_OLC_D_302	6%	46%	0.294	0.847	1.03	1.05	1	1	0	0	36%	0.36
6REZ_OLC_B_303	2%	27%	0.426	0.802	1.53	1.44	1	2	0	0	40%	0.4
6YC1_OLC_D_308	48%	43%	0.122	0.943	1.23	0.98	1	2	0	0	56%	0.56
6RF3_OLC_D_307	43%	41%	0.123	0.924	1.24	1.05	1	2	0	0	56%	0.56
6YC3_OLC_D_307	40%	44%	0.149	0.937	1.21	0.95	1	2	0	0	56%	0.56
6RF4_OLC_B_301	39%	50%	0.16	0.886	1	0.92	1	1	4	0	88%	0.88
6RFC_OLC_A_328	30%	56%	0.176	0.839	0.91	0.78	1	1	0	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	59%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	54%	0.146	0.929	0.69	1.07	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.